Scientific Research Team

The Scientific Research Team at Lycia Therapeutics drives the development and optimization of the lysosomal targeting chimeras (LYTAC) platform. This team conducts rigorous experimental research, designs and synthesizes chemical compounds, and performs detailed analyses to target and degrade extracellular proteins, advancing the company’s innovative therapeutic solutions.